MAPT and Parkinson disease: Several studies showed increased CSF levels of t-Tau and p-Tau in PDD subjects compared with HC [122,123]: PD patients with a high p-Tau and p-Tau/Aβ42 ratio developed subsequent decline in cognitive tasks, particularly memory and executive functions [124].